Sodium borate

Last content change Dec 31, 2015checked dailysee data sync status

This product has been discontinued

DISCLAIMER: This homeopathic product has not been evaluated by the Food and Drug Administration for safety or efficacy. FDA is not aware of scientific evidence to support homeopathy as effective.

Active ingredient: Sodium Borate 1 [hp_X]
Other brand names: Borax (by Boiron)
Borax (by Boiron)
Borax (by Boiron)
Borax (by Boiron)
Borax (by Boiron)
Borax (by Boiron)
Borax (by Boiron)
Borax (by Boiron)
Borax (by Boiron)
Borax (by Boiron)
Borax (by Hahnemann Laboratories, Inc.)
Borax (by Ohm Pharma Inc.)
Borax (by Rxhomeo Private Limited D. B. a. Rxhomeo, Inc)
Borax (by Rxhomeo Private Limited D. B. a. Rxhomeo, Inc)
Borax (by Sevene Usa)
Borax (by Sevene Usa)
Borax (by Warsan Homeopathic)
Borax (by Warsan Homeopathic)
Borax 30c (by Paramesh Banerji Life Sciences Llc)
View full label-group details →
Dosage form: Tablet
Route: Oral
Prescription status: Homeopathic
Marketed in the U.S.: Since 2015
Label revision date: December 31, 2015
Manufacturer Document: Prescribing information, PDF file

Active ingredient: Sodium Borate 1 [hp_X]
Other brand names: Borax (by Boiron)
Borax (by Boiron)
Borax (by Boiron)
Borax (by Boiron)
Borax (by Boiron)
Borax (by Boiron)
Borax (by Boiron)
Borax (by Boiron)
Borax (by Boiron)
Borax (by Boiron)
Borax (by Hahnemann Laboratories, Inc.)
Borax (by Ohm Pharma Inc.)
Borax (by Rxhomeo Private Limited D. B. a. Rxhomeo, Inc)
Borax (by Rxhomeo Private Limited D. B. a. Rxhomeo, Inc)
Borax (by Sevene Usa)
Borax (by Sevene Usa)
Borax (by Warsan Homeopathic)
Borax (by Warsan Homeopathic)
Borax 30c (by Paramesh Banerji Life Sciences Llc)
View full label-group details →
Dosage form: Tablet
Route: Oral
Prescription status: Homeopathic
CSA schedule: Not a scheduled drug
Marketed in the U.S.: Since 2015
Label revision date: December 31, 2015
Manufacturer: Rxhomeo Private Limited d. b. a. Rxhomeo, Inc
NDC root: 15631-0541
Manufacturer Document: Prescribing information, PDF file

Packaging Info (8 NDCs)

Packaging & NDC Codes (8)

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

If you are a consumer or patient please visit this version.

Drug Overview

You may be wondering about a medication that is used for specific conditions as directed by your physician. This drug is designed to help manage certain health issues, providing support based on your individual needs.

It's important to follow your doctor's guidance on how to use this medication effectively. If you have any questions about its purpose or how it can help you, don't hesitate to reach out to your healthcare provider for more information.

Uses

You may be prescribed this medication for a specific condition as determined by your doctor. It's important to follow their guidance on how to use it effectively. If you have any questions about your treatment or the condition being addressed, don't hesitate to reach out to your healthcare provider for more information.

Dosage and Administration

When taking this medication, adults should take either 4 or 6 tablets by mouth three times a day, or follow your doctor's specific instructions. It's important to stick to this schedule to ensure the medication works effectively.

For children aged 2 years and older, the dosage is different. They should take half of the adult dose, so if an adult takes 4 tablets, a child would take 2 tablets, and if an adult takes 6 tablets, a child would take 3 tablets. Always consult with a healthcare professional if you have any questions about the right dosage for you or your child.

Warnings and Precautions

This product is intended for short-term use to help with self-limiting conditions, meaning it should only be used for issues that typically resolve on their own. If your symptoms do not improve within four days or if they worsen, it’s important to stop using the product and consult a healthcare professional for further guidance.

If you are pregnant or nursing, please seek advice from a healthcare provider before using this medication. Always keep this and all medications out of reach of children to prevent accidental ingestion. Additionally, do not use the product if the cap seal is broken or missing, and remember to close the cap tightly after each use to maintain its effectiveness.

Overdose

If you suspect an overdose, it's important to stay calm and take immediate action. While there is no specific information available about the signs of overdose for this medication, general symptoms can include unusual drowsiness, confusion, or difficulty breathing. If you notice any of these signs, or if you are unsure, seek medical help right away.

In case of an overdose, contact your local emergency services or go to the nearest hospital. It's always better to be safe and get checked by a healthcare professional if you have any concerns about your health. Remember, timely intervention can make a significant difference.

Storage and Handling

To ensure the best performance and safety of your product, store it in a cool, dark place. This helps maintain its effectiveness and prevents any degradation. When handling the product, be sure to follow any specific instructions provided to avoid contamination or damage. Always check for any additional components that may be included, as they are essential for safe and proper use. If you have any questions about disposal or further handling, consult the guidelines provided with your product.

Additional Information

No further information is available.

FAQ

What conditions can this product be used for?

This product is to be used for self-limiting conditions as listed above or as directed by your physician.

What is the recommended dosage for adults?

Adults should take 4 or 6 tablets by mouth, three times daily or as suggested by your physician.

What is the recommended dosage for children?

Children 2 years and older should take half the adult dose.

What should I do if my symptoms do not improve?

If your symptoms do not improve in 4 days or worsen, discontinue use and seek assistance from a health professional.

Can I use this product if I am pregnant or nursing?

If you are pregnant or nursing a baby, seek professional advice before taking this product.

How should I store this medication?

Store this medication in a cool, dark place and keep it out of reach of children.

What should I do if the capseal is broken or missing?

Do not use the product if the capseal is broken or missing.

What should I do after using the product?

Close the cap tightly after use to ensure the product remains effective.

Packaging Info

This section summarizes the homeopathic presentations of Borax. Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Borax.

	1 in blister pack 1 item total	Tablet	1 [hp_X]
Product details Regulatory status — Discontinued NSDE (NDC Directory) reports this NDC as Not Marketed. FDA record dates for this NDC: NSDE file: February 16, 2026 → status: Not marketed Type Type 0: Not a Combination Product Active ingredients Sodium Borate 1 [hp_X] Inactive ingredients lactose
	4 in blister pack 4 items total	Tablet	1 [hp_X]
Product details Regulatory status — Discontinued NSDE (NDC Directory) reports this NDC as Not Marketed. FDA record dates for this NDC: NSDE file: February 16, 2026 → status: Not marketed Type Type 0: Not a Combination Product Active ingredients Sodium Borate 1 [hp_X] Inactive ingredients lactose
	50 in container 50 items total	Tablet	1 [hp_X]
Product details Regulatory status — Discontinued NSDE (NDC Directory) reports this NDC as Not Marketed. FDA record dates for this NDC: NSDE file: February 16, 2026 → status: Not marketed Type Type 0: Not a Combination Product Active ingredients Sodium Borate 1 [hp_X] Inactive ingredients lactose
	100 in container 100 items total	Tablet	1 [hp_X]
Product details Regulatory status — Discontinued NSDE (NDC Directory) reports this NDC as Not Marketed. FDA record dates for this NDC: NSDE file: February 16, 2026 → status: Not marketed Type Type 0: Not a Combination Product Active ingredients Sodium Borate 1 [hp_X] Inactive ingredients lactose
	250 in container 250 items total	Tablet	1 [hp_X]
Product details Regulatory status — Discontinued NSDE (NDC Directory) reports this NDC as Not Marketed. FDA record dates for this NDC: NSDE file: February 16, 2026 → status: Not marketed Type Type 0: Not a Combination Product Active ingredients Sodium Borate 1 [hp_X] Inactive ingredients lactose
	500 in container 500 items total	Tablet	1 [hp_X]
Product details Regulatory status — Discontinued NSDE (NDC Directory) reports this NDC as Not Marketed. FDA record dates for this NDC: NSDE file: February 16, 2026 → status: Not marketed Type Type 0: Not a Combination Product Active ingredients Sodium Borate 1 [hp_X] Inactive ingredients lactose
	1000 in container 1000 items total	Tablet	1 [hp_X]
Product details Regulatory status — Discontinued NSDE (NDC Directory) reports this NDC as Not Marketed. FDA record dates for this NDC: NSDE file: February 16, 2026 → status: Not marketed Type Type 0: Not a Combination Product Active ingredients Sodium Borate 1 [hp_X] Inactive ingredients lactose
	10000 in container 10000 items total	Tablet	1 [hp_X]
Product details Regulatory status — Discontinued NSDE (NDC Directory) reports this NDC as Not Marketed. FDA record dates for this NDC: NSDE file: February 16, 2026 → status: Not marketed Type Type 0: Not a Combination Product Active ingredients Sodium Borate 1 [hp_X] Inactive ingredients lactose

Manufacturer Insert (PDF)

This file includes usage instructions and other product details provided by the manufacturer. This is not an FDA-approved drug.

View manufacturer document (PDF)

Description

Description:

This product contains BORAX HPUS 1X and higher as the active ingredient, with sodium borate (UNII: 91MBZ8H3QO) and borate ion (UNII: 44OAE30D22) as the primary component. The formulation includes lactose as an inactive ingredient. The product is presented in a round shape, measuring 3 mm in size, and is characterized by its white color. It does not have a score line. The route of administration is oral, and the strength of the active ingredient is sodium borate 1 hp_X.

Packaging & NDC

This section summarizes the homeopathic presentations of Borax. Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Borax.

	1 in blister pack 1 item total	Tablet	1 [hp_X]
Product details Regulatory status — Discontinued NSDE (NDC Directory) reports this NDC as Not Marketed. FDA record dates for this NDC: NSDE file: February 16, 2026 → status: Not marketed Type Type 0: Not a Combination Product Active ingredients Sodium Borate 1 [hp_X] Inactive ingredients lactose
	4 in blister pack 4 items total	Tablet	1 [hp_X]
Product details Regulatory status — Discontinued NSDE (NDC Directory) reports this NDC as Not Marketed. FDA record dates for this NDC: NSDE file: February 16, 2026 → status: Not marketed Type Type 0: Not a Combination Product Active ingredients Sodium Borate 1 [hp_X] Inactive ingredients lactose
	50 in container 50 items total	Tablet	1 [hp_X]
Product details Regulatory status — Discontinued NSDE (NDC Directory) reports this NDC as Not Marketed. FDA record dates for this NDC: NSDE file: February 16, 2026 → status: Not marketed Type Type 0: Not a Combination Product Active ingredients Sodium Borate 1 [hp_X] Inactive ingredients lactose
	100 in container 100 items total	Tablet	1 [hp_X]
Product details Regulatory status — Discontinued NSDE (NDC Directory) reports this NDC as Not Marketed. FDA record dates for this NDC: NSDE file: February 16, 2026 → status: Not marketed Type Type 0: Not a Combination Product Active ingredients Sodium Borate 1 [hp_X] Inactive ingredients lactose
	250 in container 250 items total	Tablet	1 [hp_X]
Product details Regulatory status — Discontinued NSDE (NDC Directory) reports this NDC as Not Marketed. FDA record dates for this NDC: NSDE file: February 16, 2026 → status: Not marketed Type Type 0: Not a Combination Product Active ingredients Sodium Borate 1 [hp_X] Inactive ingredients lactose
	500 in container 500 items total	Tablet	1 [hp_X]
Product details Regulatory status — Discontinued NSDE (NDC Directory) reports this NDC as Not Marketed. FDA record dates for this NDC: NSDE file: February 16, 2026 → status: Not marketed Type Type 0: Not a Combination Product Active ingredients Sodium Borate 1 [hp_X] Inactive ingredients lactose
	1000 in container 1000 items total	Tablet	1 [hp_X]
Product details Regulatory status — Discontinued NSDE (NDC Directory) reports this NDC as Not Marketed. FDA record dates for this NDC: NSDE file: February 16, 2026 → status: Not marketed Type Type 0: Not a Combination Product Active ingredients Sodium Borate 1 [hp_X] Inactive ingredients lactose
	10000 in container 10000 items total	Tablet	1 [hp_X]
Product details Regulatory status — Discontinued NSDE (NDC Directory) reports this NDC as Not Marketed. FDA record dates for this NDC: NSDE file: February 16, 2026 → status: Not marketed Type Type 0: Not a Combination Product Active ingredients Sodium Borate 1 [hp_X] Inactive ingredients lactose

Manufacturer Insert (PDF)

This is the product document submitted by Rxhomeo Private Limited d. b. a. Rxhomeo, Inc for Borax. It includes information on ingredients, suggested use, and labeling language. This product is not FDA-approved.

View product insert (PDF)

Data Generation & Sources

This page was automatically generated and is maintained by the AllDrugs AI Data-Science Team. It was built from the manufacturer-supplied FDA Structured Product Label (DailyMed) for Borax, retrieved February 18, 2026 by a validated AI data-extraction workflow.

All dosage forms and strengths provided by the manufacturer are listed in the Packaging & NDC Codes section above.

Homeopathic drug products are not reviewed by FDA for safety or effectiveness; information is reproduced without modification.

No human clinician has reviewed this version.

Learn more in our Editorial Policy

Last AI update: February 18, 2026

Primary FDA sources:

Orange Book data shown on this page are limited to Regulatory Status (Rx), Established Pharmacologic Class (EPC), and Mechanism of Action (MoA).

Regulatory data notice: Information on this page is reproduced verbatim from FDA public databases (NSDE, Orange Book, Purple Book, DailyMed SPL). NDA/ANDA drugs are FDA-approved, BLA biologics are FDA-licensed. Inclusion alone does not guarantee current market availability or imply FDA endorsement.

Medical disclaimer: This AI-generated content is provided for educational purposes only and does not constitute medical advice. Always consult a licensed healthcare professional for diagnosis or treatment decisions.